Related Experiment Videos
[Fluorescence cystoscopy in bladder cancer: what future?].
P Jichlinski1, A Marti, H J Leisinger
1Service d'urologie, centre hospitalier universitaire Vaudois, 1011 Lausanne, Suisse. Patrice.Jichlinski@chuv.hospvd.ch
Annales D'Urologie
|August 7, 2002
Summary
Superficial bladder cancer has a high recurrence rate. New fluorescence cystoscopy techniques improve tumor detection, potentially reducing recurrence, but long-term impact needs further study.
Area of Science:
- Uro-oncology
- Diagnostic Imaging
- Endoscopic Technology
Context:
- Bladder transitional cell carcinoma, often superficial, presents a significant challenge due to high recurrence rates (up to 70% within three years).
- Advancements in endoscopic techniques have shown promise in reducing short-term recurrence rates.
- There is a need for improved diagnostic methods to enhance tumor visualization and mapping.
Purpose:
- To evaluate the efficacy of novel fluorescence detection methods in improving the diagnosis of bladder cancer.
- To assess the potential of fluorescence cystoscopy in enhancing visual contrast between cancerous and normal bladder tissue.
- To determine the sensitivity of fluorescence cystoscopy in detecting carcinoma in situ (CIS).
Summary:
- Superficial bladder transitional cell carcinoma has a high recurrence rate, but endoscopic technique evolution has reduced it at three months.
- New fluorescence cystoscopy methods aim to improve tumor detection by enhancing visual contrast, aiding precise bladder mapping.
- This technique demonstrates high sensitivity (80-90%) for detecting carcinoma in situ (CIS).
Impact:
- Fluorescence cystoscopy offers improved visualization for bladder cancer diagnosis and mapping.
- The enhanced detection may lead to more accurate staging and treatment planning.
- Further research is required to demonstrate the impact of fluorescence cystoscopy on long-term disease progression.